Relationship between menopausal hormone therapy and breast cancer: A nationwide population-based cohort study.

Jin-Sung Yuk

Published in: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics (2024)

MHT was linked to increased breast cancer risk, but not all MHTs. Specific combined therapies (EH/DRSP, EH/DYD, EH/NETA, and EV/CPA) were associated with higher risk, whereas estrogen alone and tibolone were not.

Keyphrases

breast cancer risk
estrogen receptor
stem cells
young adults
smoking cessation